Search > Results

You searched for: EV210305 (EV-TRACK ID)

Showing 1 - 10 of 10

Experiment number
  • If needed, multiple experiments were identified in a single publication based on differing sample types, separation protocols and/or vesicle types of interest.
Species
  • Species of origin of the EVs.
Separation protocol
  • Gives a short, non-chronological overview of the different steps of the separation protocol.
    • (d)(U)C = (differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Details EV-TRACK ID Experiment nr. Species Sample type Separation protocol First author Year EV-METRIC
EV210305 2/10 Homo sapiens urine Lectin affinity capture (Lotus tetragonolobus)
PEG precipitation
Isaksson, Gustaf L. 2021 50%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant recipient controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Lectin affinity capture (Lotus tetragonolobus)
PEG precipitation
Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Lotus tetragonolobus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
AQP2/ CR1/ Podocalyxin
Not detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
EV210305 3/10 Homo sapiens urine Lectin affinity capture (Dolichus biflorus)
PEG precipitation
Isaksson, Gustaf L. 2021 50%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant recipient controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Lectin affinity capture (Dolichus biflorus)
PEG precipitation
Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Dolichus biflorus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CR1/ Podocalyxin
Detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
EV210305 7/10 Homo sapiens urine Lectin affinity capture (Lotus tetragonolobus)
PEG precipitation
Isaksson, Gustaf L. 2021 50%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Lectin affinity capture (Lotus tetragonolobus)
PEG precipitation
Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Lotus tetragonolobus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
AQP2/ CR1/ Podocalyxin
Not detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
EV210305 8/10 Homo sapiens urine Lectin affinity capture (Dolichus biflorus)
PEG precipitation
Isaksson, Gustaf L. 2021 50%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Lectin affinity capture (Dolichus biflorus)
PEG precipitation
Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Dolichus biflorus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CR1/ Podocalyxin
Detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
EV210305 9/10 Homo sapiens urine IAF
PEG precipitation
Isaksson, Gustaf L. 2021 50%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Immunoaffinity capture (non-commercial)
PEG precipitation
Protein markers
EV: C9 neoantigen/ iC3b/C3dg/ CD63/ TSG101/ SGLT2
non-EV: None
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C3dg
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CD63/ TSG101
Characterization: Lipid analysis
No
EV210305 1/10 Homo sapiens urine (d)(U)C Isaksson, Gustaf L. 2021 44%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
44% (80th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant recipient controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
(Differential) (ultra)centrifugation
Protein markers
EV: CD63/ C9 neoantigen
non-EV: None
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Equal to or above 150,000 g
Pelleting performed
Yes
Pelleting: time(min)
100
Pelleting: rotor type
Type 70-Ti
Pelleting: speed (g)
220,000
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD63/ C9 neoantigen
Characterization: Lipid analysis
No
EV210305 6/10 Homo sapiens urine (d)(U)C Isaksson, Gustaf L. 2021 44%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
44% (80th percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
(Differential) (ultra)centrifugation
Protein markers
EV: CD63/ C9 neoantigen
non-EV: None
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Equal to or above 150,000 g
Pelleting performed
Yes
Pelleting: time(min)
100
Pelleting: rotor type
Type 70-Ti
Pelleting: speed (g)
220000
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD63/ C9 neoantigen
Characterization: Lipid analysis
No
EV210305 4/10 Homo sapiens urine IAF
PEG precipitation
Isaksson, Gustaf L. 2021 38%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
38% (73rd percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant recipients controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Immunoaffinity capture (non-commercial)
PEG precipitation
Protein markers
EV: C9 neoantigen/ iC3b/C3dg/ CD63/ TSG101/ SGLT2
non-EV: None
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C3dg
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CD63/ TSG101
Characterization: Lipid analysis
No
EV210305 5/10 Homo sapiens urine IAF
PEG precipitation
Isaksson, Gustaf L. 2021 38%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
38% (73rd percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant recipients controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Immunoaffinity capture (non-commercial)
PEG precipitation
Protein markers
EV: C9 neoantigen/ CD63/ TSG101/ SGLT2
non-EV: None
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C9
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ CD63/ SGLT2
Not detected EV-associated proteins
TSG101
Characterization: Lipid analysis
No
EV210305 10/10 Homo sapiens urine IAF
PEG precipitation
Isaksson, Gustaf L. 2021 38%

Study summary

Full title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). We hypothesized that aberrant filtration of complement factors causes intraluminal activation, apical membrane attack on tubular cells and progressive injury. Biobanked samples from two previous studies in albuminuric KTRs were used. Complement activation split products C3c, C3dg and sC5b-9 associated C9 neoantigen were analyzed by ELISA in urine and plasma using neoepitope-specific antibodies. Urinary extracellular vesicles (uEV) were enriched by lectin- and immunoaffinity-isolation and analyzed by immunoblotting. Urine complement excretion increased significantly in KTRs with albumin/creatinine ratio ≥ 300 mg/g compared to < 30 mg/g. Urine C3dg and C9 neoantigen excretion correlated significantly to changes in albumin excretion from 3 to 12 months after transplantation. The fractional excretion of C9 neoantigen was significantly higher than for albumin indicating post-filtration generation. C9 neoantigen was detected in uEVs in six of nine of albuminuric KTRs but was absent in non-albuminuric controls (n = 8). In C9 neoantigen positive KTRs, lectin-affinity enrichment of uEVs from the proximal tubules yielded signal for iC3b, C3dg, C9 neoantigen and SGLT2 but only weakly for AQP2. Co-isolation of podocyte markers and Tamm-Horsfall protein was minimal. Our findings show that albuminuria is associated with aberrant filtration and intratubular activation of complement with deposition of C3 activation split products and C5b-9 associated C9 neoantigen on uEVs from the proximal tubular apical membrane. Intratubular complement activation may contribute to progressive kidney injury in proteinuric kidney grafts. (hide)
EV-METRIC
38% (73rd percentile of all experiments on the same sample type)
 Reported
 Not reported
 Not applicable
EV-enriched proteins
Protein analysis: analysis of three or more EV-enriched proteins
non EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody specifics
Protein analysis: antibody clone/reference number and dilution
lysate preparation
Protein analysis: lysis buffer composition
Study data
Sample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
  • Gives a short, non-chronological overview of the
    different steps of the separation protocol.
    • dUC = (Differential) (ultra)centrifugation
    • DG = density gradient
    • UF = ultrafiltration
    • SEC = size-exclusion chromatography
    • IAF = immuno-affinity capture
Immunoaffinity capture (non-commercial)
PEG precipitation
Protein markers
EV: C9 neoantigen/ CD63/ TSG101/ SGLT2
non-EV: None
Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C9
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ CD63/ SGLT2
Not detected EV-associated proteins
TSG101
Characterization: Lipid analysis
No
1 - 10 of 10
  • CM = Commercial method
  • dUC = differential ultracentrifugation
  • DG = density gradient
  • UF = ultrafiltration
  • SEC = size-exclusion chromatography
EV-TRACK ID
EV210305
species
Homo
sapiens
sample type
urine
condition
Kidney
transplant
recipient
controls
Kidney
transplant
recipient
controls
Kidney
transplant
albuminuria
Kidney
transplant
albuminuria
Kidney
transplant
albuminuria
Kidney
transplant
recipient
controls
Kidney
transplant
albuminuria
Kidney
transplant
recipients
controls
Kidney
transplant
recipients
controls
Kidney
transplant
albuminuria
separation protocol
Lectin
affinity
capture
(Lotus
tetragonolobus)/
PEG
precipitation
Lectin
affinity
capture
(Dolichus
biflorus)/
PEG
precipitation
Lectin
affinity
capture
(Lotus
tetragonolobus)/
PEG
precipitation
Lectin
affinity
capture
(Dolichus
biflorus)/
PEG
precipitation
IAF
capture
(non-commercial)/
PEG
precipitation
dUC
dUC
IAF
capture
(non-commercial)/
PEG
precipitation
IAF
capture
(non-commercial)/
PEG
precipitation
IAF
capture
(non-commercial)/
PEG
precipitation
Exp. nr.
2
3
7
8
9
1
6
4
5
10
EV-METRIC %
50
50
50
50
50
44
44
38
38
38